about
What is known about melatonin, chemotherapy and altered gene expression in breast cancerAntitumor mechanisms of S-allyl mercaptocysteine for breast cancer therapy.Breast conserving surgery versus mastectomy: the influence of comorbidities on choice of surgical operation in the Department of Defense health care systemAn integrated microfluidic cell array for apoptosis and proliferation analysis induction of breast cancer cellsThe use of rehabilitation among patients with breast cancer: a retrospective longitudinal cohort study.Histological, molecular and functional subtypes of breast cancersScreening ultrasound as an adjunct to mammography in women with mammographically dense breastsProtein arginine methyltransferase 7 promotes breast cancer cell invasion through the induction of MMP9 expressionCationic albumin nanoparticles for enhanced drug delivery to treat breast cancer: preparation and in vitro assessment.Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenograftsIdentification of genes involved in breast cancer and breast cancer stem cells.Combination drug delivery approaches in metastatic breast cancerSequencing Strategies to Guide Decision Making in Cancer Treatment.Knockdown of eIF3D inhibits breast cancer cell proliferation and invasion through suppressing the Wnt/β-catenin signaling pathway.ING5 inhibits epithelial-mesenchymal transition in breast cancer by suppressing PI3K/Akt pathway.Effects of methylglyoxal and glyoxalase I inhibition on breast cancer cells proliferation, invasion, and apoptosis through modulation of MAPKs, MMP9, and Bcl-2.Tannic Acid preferentially targets estrogen receptor-positive breast cancer.Basic research and clinical applications of bisphosphonates in bone disease: what have we learned over the last 40 years?Development of a new class of aromatase inhibitors: design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivativesAssessment of general characteristics of patients with primary metastatic breast carcinoma: single center experience.Risk Factors Associated with Lymphedema among Postmenopausal Breast Cancer Survivors after Radical Mastectomy and Axillary Dissection in ChinaDetection of Methylated Circulating DNA as Noninvasive Biomarkers for Breast Cancer DiagnosisEffects of Sexual Rehabilitation Using the PLISSIT Model on Quality of Sexual Life and Sexual Functioning in Post-Mastectomy Breast Cancer SurvivorsOptimizing post-acute care in breast cancer survivors: a rehabilitation perspective.Δ2-Troglitazone promotes cytostatic rather than pro-apoptotic effects in breast cancer cells cultured in high serum conditions.Feasibility study of individualized optimal positioning selection for left-sided whole breast radiotherapy: DIBH or prone.Physical and Emotional Experiences of Chemotherapy: a Qualitative Study among Women with Breast Cancer in Southern Thailand
P2860
Q33597963-D5FB6367-08AC-4EAE-A8E9-BB655E9D7476Q34006770-A03AA6C4-3BF4-46F7-9C2F-FDB5775F9E00Q34107526-75CC02E6-73A7-4D89-AC81-4DAFFDC0E0AEQ34252992-695A2148-EB30-4B1B-9583-150AECF6A840Q34396585-9FE56404-996E-4842-829B-FC93253449F3Q34616569-FA74F343-E2C9-4D04-8671-455A01F23CD1Q35353726-68293F08-7AB2-433B-817D-41523242BBFFQ35550160-60BDB6D3-0DAF-4C9F-A742-E82F8289C938Q35609201-21775DFC-61C7-48DE-AFD3-7DA45349A4E4Q35683602-89982AAD-3334-4C0E-9D15-9E176B4ABE09Q35866409-B95568EA-BD81-4F9B-BB59-E06440CD1A1AQ35955198-9FF80496-5888-4DDE-A855-70C543A12DD7Q36214189-CEF00F40-D716-41E7-B33D-46B5519AAF4CQ36261389-894B127F-65DB-4ACF-8566-D85DA46225A6Q36317550-32913C5E-6957-46D2-BE53-DB416A6CF3CCQ36844345-CD81B630-F1AF-4953-82C4-0D4462889997Q37392968-B8EDFC70-6AEE-4EAF-91F1-63C7893CB7D1Q37418042-5F9CA431-DEDF-4B51-A3C8-28E584D6883EQ37601689-4C169D09-0B0C-4AA4-A1E3-0E1812BA75BAQ37601851-19032817-C719-4372-AC96-1BC3C01E2BEEQ37677687-6B8B0A79-47EF-4A0A-8A7D-AA0ED298A98EQ37735951-5FAF75CA-95F3-4D5D-A874-0127460CCE7CQ39057831-9F42BEF3-6F65-477E-8991-5A19671F2218Q41633994-EFF05E77-2B5C-4B35-8096-3C99E080D908Q42331869-686052C6-8959-4FE5-A663-92B4ABAFF1D7Q50049599-4C2D9833-7E24-41D5-AF13-B981F90763D7Q57132811-0BD7241E-59FB-490F-A80D-464CD5D872F0
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Treatment of breast cancer.
@ast
Treatment of breast cancer.
@en
type
label
Treatment of breast cancer.
@ast
Treatment of breast cancer.
@en
prefLabel
Treatment of breast cancer.
@ast
Treatment of breast cancer.
@en
P2093
P1476
Treatment of breast cancer.
@en
P2093
Karen L Maughan
Mark A Lutterbie
Peter S Ham
P304
P577
2010-06-01T00:00:00Z